Skip to Content

Types of Lung Cancer

Mesothelioma

Mesothelioma is a type of cancer that affects the mesothelium, which is a thin layer of tissue that covers all of your internal organs. This type of cancer is most frequently seen in the mesothelium that covers the lungs, and we believe that exposure to the chemical asbestos is the primary cause of mesothelioma. Unfortunately, there is no cure for this type of cancer; however, at Mount Sinai we have a number of treatments available to slow the progression of the disease and to help improve the quality of life for patients diagnosed with mesothelioma.

Treatments

Since most patients with mesothelioma are diagnosed after their disease has advanced, surgery to remove the cancer is rarely an option. However, at Mount Sinai we use surgical approaches for managing the disease, including to remove excess fluid that accumulates around the lungs, to remove one of the affected lungs, or to remove part of the mesothelium to make patients more comfortable. In addition, certain chemotherapies and radiation treatment have been shown to slow progression of the disease and to alleviate symptoms and pain.

Non-Small Cell Lung Cancer

Non-small cell lung cancer is the most common type of lung cancer, making up 85% of new cases and affecting 200,000 people each year. While non-smokers can get non-small cell lung cancer, smoking cigarettes is the greatest risk factor. Quitting smoking or not smoking at all are the best steps people can take to avoid developing this type of lung cancer.

The name comes from how this type of cancer cells looks under a microscope. The disease develops from the cells that line the inside of the lungs. 

Treatments

For more than 40% of people diagnosed with non-small cell lung cancer, their disease has already spread beyond their lungs at the time they’re diagnosed. However, for those who are diagnosed early, surgery to remove the primary tumor or tumors is a viable treatment approach. For those whose cancer has already spread, we use different chemotherapies, radiation therapy, and targeted immunotherapies to destroy as much cancer as possible.

Treatment options for patients with non-small cell lung cancer have increased significantly just in the past few years. Several new drugs have been approved that have been shown to be effective in prolonging the lives of people with non-small cell lung cancer.

Small Cell (Oat Cell) Lung Cancer

Small cell lung cancer is the least common type of lung cancer, and it is also faster growing and more likely to spread quickly than the more common non-small cell lung cancer. This type of cancer is also sometimes called oat cell lung cancer because the cancer cells have an oval shape that resembles a grain of oat.

Like most lung cancers, patients with small cell lung cancer are rarely diagnosed until after their disease has spread beyond their lungs. This makes treatment more difficult and less successful. In addition, adding to the challenge, small cell lung cancer is more likely to come back, or recur, after treatment.

Treatments

Small cell lung cancer is most effectively treated when diagnosed early. In these instances, radiation therapy, chemotherapy, and immunotherapy have the potential to provide favorable results.

Our Physicians

Roy F Williams, MD

Chief, Divison of Thoracic Surgery

  • Cardiology
  • Robotic Surgery
  • Thoracic & Cardiovascular Surgery
  • Lung Cancer

Fernando Safdie, MD

Director of Endoluminal and Airway Surgery

Associate Director of Thoracic Surgery

Division of Cardiothoracic Surgery

  • Robotic Surgery
  • Thoracic & Cardiovascular Surgery
  • Lung Cancer

Mike Cusnir, MD

Chief, Division of Hematology & Oncology

Co-Director, Gastrointestinal Malignancies

Assistant Professor at the Columbia University Division of Hematology/Oncology at Mount Sinai Medical Center

  • Cancer
  • Oncology
  • Medical Oncology
  • Hematology/Oncology

Nicolas Keith Kuritzky, MD

Chief, Division of Radiation Oncology

  • Cancer
  • Radiation Oncology

Michael Alan Schwartz, MD

Principal Investigator, Mount Sinai Cancer Research Program

Assistant Professor at the Columbia University Division of Hematology/Oncology at Mount Sinai Medical Center

  • Cancer
  • Oncology
  • Medical Oncology
  • Hematology/Oncology
  • Lung Cancer

Oleg Gligich, MD

Assistant Professor at the Columbia University Division of Hematology/Oncology at Mount Sinai Medical Center

  • Cancer
  • Hematology/Oncology

There are no results

Aron Simkins, MD

Associate Professor at the Columbia University Division of Hematology/Oncology at Mount Sinai Medical Center

  • Cancer
  • Hematology/Oncology
  • Lung Cancer
  • Gastrointestinal Malignancies

Debra Linzer, MD

  • Cancer
  • Radiation Oncology
Back to top